Osteoarthritis and Cartilage
Volume 18, Issue 2 , Pages 141-149, February 2010

Biological actions of curcumin on articular chondrocytes

  • Y. Henrotin

      Affiliations

    • Bone and Cartilage Research Unit, University of Liège, Institute of Pathology, Sart-Tilman, 4000 Liège, Belgium
    • Corresponding Author InformationAddress correspondence and reprint requests to: Yves Henrotin, University of Liège, Bone and Cartilage Research Unit, Institute of Pathology, Level +5, CHU Sart-Tilman, 4000 Liège, Belgium. Tel: 32-4-366-25-16; Fax: 32-4-3664734.
    • These authors contributed equally to this paper.
  • ,
  • A.L. Clutterbuck

      Affiliations

    • Musculoskeletal Research Group, Division of Veterinary Medicine, School of Veterinary Medicine and Science, Institute of Clinical Research and the Faculty of Medicine and Health Sciences, University of Nottingham, Sutton Bonington Campus, Loughborough, Leicestershire LE12 5RD, United Kingdom
  • ,
  • D. Allaway

      Affiliations

    • WALTHAM Centre for Pet Nutrition, Waltham-on-the-Wolds, Melton Mowbray, Leicestershire LE14 4RT, United Kingdom
  • ,
  • E.M. Lodwig

      Affiliations

    • WALTHAM Centre for Pet Nutrition, Waltham-on-the-Wolds, Melton Mowbray, Leicestershire LE14 4RT, United Kingdom
  • ,
  • P. Harris

      Affiliations

    • WALTHAM Centre for Pet Nutrition, Waltham-on-the-Wolds, Melton Mowbray, Leicestershire LE14 4RT, United Kingdom
  • ,
  • M. Mathy-Hartert

      Affiliations

    • Bone and Cartilage Research Unit, University of Liège, Institute of Pathology, Sart-Tilman, 4000 Liège, Belgium
  • ,
  • M. Shakibaei

      Affiliations

    • Musculoskeletal Research Group, Institute of Anatomy, Ludwig-Maximilians-University Munich, D-80336 Munich, Germany
  • ,
  • A. Mobasheri

      Affiliations

    • Musculoskeletal Research Group, Division of Veterinary Medicine, School of Veterinary Medicine and Science, Institute of Clinical Research and the Faculty of Medicine and Health Sciences, University of Nottingham, Sutton Bonington Campus, Loughborough, Leicestershire LE12 5RD, United Kingdom
    • These authors contributed equally to this paper.

Received 9 April 2009; accepted 1 October 2009. published online 26 October 2009.

Summary 

Objectives

Curcumin (diferuloylmethane) is the principal biochemical component of the spice turmeric and has been shown to possess potent anti-catabolic, anti-inflammatory and antioxidant, properties. This article aims to provide a summary of the actions of curcumin on articular chondrocytes from the available literature with the use of a text-mining tool. We highlight both the potential benefits and drawbacks of using this chemopreventive agent for treating osteoarthritis (OA). We also explore the recent literature on the molecular mechanisms of curcumin mediated alterations in gene expression mediated via activator protein 1 (AP-1)/nuclear factor-kappa B (NF-κB) signalling in chondrocytes, osteoblasts and synovial fibroblasts.

Methods

A computer-aided search of the PubMed/Medline database aided by a text-mining tool to interrogate the ResNet Mammalian database 6.0.

Results

Recent work has shown that curcumin protects human chondrocytes from the catabolic actions of interleukin-1 beta (IL-1β) including matrix metalloproteinase (MMP)-3 up-regulation, inhibition of collagen type II and down-regulation of β1-integrin expression. Curcumin blocks IL-1β-induced proteoglycan degradation, AP-1/NF-κB signalling, chondrocyte apoptosis and activation of caspase-3.

Conclusions

The available data from published in vitro and in vivo studies suggest that curcumin may be a beneficial complementary treatment for OA in humans and companion animals. Nevertheless, before initiating extensive clinical trials, more basic research is required to improve its solubility, absorption and bioavailability and gain additional information about its safety and efficacy in different species. Once these obstacles have been overcome, curcumin and structurally related biochemicals may become safer and more suitable nutraceutical alternatives to the non-steroidal anti-inflammatory drugs that are currently used for the treatment of OA.

Key words: Articular cartilage, Osteoarthritis (OA), Curcumin, Nuclear factor kappa B (NF-κB) cell signalling, Pro-inflammatory cytokine, Inflammation, Inflammatory mediator, Cytotoxicity, Apoptosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1063-4584(09)00273-8

doi:10.1016/j.joca.2009.10.002

Osteoarthritis and Cartilage
Volume 18, Issue 2 , Pages 141-149, February 2010